Earnings Feed
Start Free
Home/Filings/4/0001493152-21-001034
4//SEC Filing

Palmedo Philip F 4

Accession 0001493152-21-001034

CIK 0001335105other
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 2:26 PM ET

Size

11.3 KB

Accession

0001493152-21-001034

Insider Transaction Report

Form 4
Period: 2021-01-06
LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT
Palmedo Philip F
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2021-01-06+50,000→ 50,000 total
    Exercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying)
Holdings

  • Options to Purchase Common Stock

    Exercise: $0.90From: 2017-10-16Exp: 2022-10-16→ Common (8,333 underlying)
    8,333

  • Options to Purchase Common Stock

    Exercise: $0.72From: 2016-04-25Exp: 2021-04-25→ Common (75,000 underlying)
    75,000

  • Warrants to Purchase Common Stock

    Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (21,053 underlying)
    21,053

  • Warrants to Purchase Common Stock

    (indirect: By Philip Palmedo L.P..)
    Exercise: $6.00From: 2018-12-07Exp: 2022-12-07→ Common (16,667 underlying)
    16,667

  • Options to Purchase Common Stock

    Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying)
    8,333

Documents

1 file

Issuer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105

→
Entity typeother

Related Parties

1
  • filerCIK 0001369455

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 2:26 PM ET
Size
11.3 KB
View on SEC.gov